Rhythm Pharmaceuticals Files 8-K
Ticker: RYTM · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
RHYTHM PHARMACEUTICALS FILED AN 8-K ON 7/9/25 - DETAILS UNCLEAR FROM THIS EXCERPT
AI Summary
On July 9, 2025, Rhythm Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events detailed in the provided text. The company is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This 8-K filing indicates Rhythm Pharmaceuticals is making a regulatory submission, though the specific details of the 'Other Events' are not elaborated in this excerpt.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate disclosure of significant negative or positive events.
Key Players & Entities
- Rhythm Pharmaceuticals, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Boston, MA (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The filing is designated for 'Other Events' and 'Financial Statements and Exhibits' as per the provided information.
When was the earliest event reported in this filing?
The earliest event reported was on July 9, 2025.
Where is Rhythm Pharmaceuticals, Inc. headquartered?
Rhythm Pharmaceuticals, Inc. is headquartered at 222 Berkeley Street, 12th Floor, Boston, MA 02116.
In which state is Rhythm Pharmaceuticals, Inc. incorporated?
Rhythm Pharmaceuticals, Inc. is incorporated in Delaware.
What is the company's telephone number?
The company's telephone number is (857) 264-4280.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).